"503A" and "503B" refer to sections of the Federal Food, Drug, and Cosmetic Act. The short version: a 503A compounds patient-specific prescriptions; a 503B is a registered outsourcing facility that manufactures compounded drugs, often without a patient-specific prescription, under cGMP and FDA oversight. The operational gap between them is larger than it sounds.
503A: patient-specific compounding
A 503A pharmacy compounds for an individual patient pursuant to a prescription. It's regulated primarily by state boards of pharmacy, follows USP standards, and doesn't require FDA registration as a manufacturer. Operationally it's prescription-driven — intake, verify, compound, dispense, ship.
503B: cGMP outsourcing facility
A 503B facility registers with the FDA, submits to FDA inspection, follows cGMP, and can produce office stock in batches for healthcare providers. It's effectively a pharmaceutical manufacturer — with batch records, environmental monitoring, stability, and a formal quality system.
What it means for operations and software
- ✓503A workflows are prescription- and patient-driven; 503B are batch- and lot-driven
- ✓503B requires cGMP batch records, environmental monitoring, and stronger QMS
- ✓Both need DEA controls, state licensure, serialization, and recall readiness
- ✓Many pharmacies run both models and need one system that supports each
Whichever model you run — or both — the platform underneath needs to enforce the right controls without forcing you into someone else's workflow. See 503A software and 503B software.
Frequently asked questions
Can one pharmacy be both 503A and 503B?+
A single legal entity generally operates under one designation, but many organizations run both a 503A pharmacy and a 503B facility — which is why unified software that supports each model matters.
Does a 503B need a patient-specific prescription?+
Not necessarily — a 503B outsourcing facility can produce office stock for healthcare providers, under cGMP and FDA oversight.
Keep reading